Not exact matches
ACEs usually refers to the 10 types of childhood adversity that were measured in the U.S. Centers for Disease Control and Prevention's Adverse Childhood Experiences (ACE)
Study: physical abuse, emotional abuse, sexual abuse, physical neglect, emotional neglect, a family member who's an alcoholic or addicted to other
drugs, a family member diagnosed with a mental illness, witnessing a mother being abused, a family member in prison, and
loss of a parent through separation or divorce.
Another weight -
loss drug approved back in 1997, Meridia, was pulled from the market under pressure from the fda after
studies showed it raises cardiovascular risk.
The
drug does not have approval for weight
loss, according to its manufacturer, Denmark - headquartered Novo Nordisk, which sponsored the
study.
«What a great
loss this is to the agency and the industry,» says Kenneth Kaitin, director of the Center for the
Study of
Drug Development at Tufts University in Boston.
«This is the first
drug molecule that can regulate memory
loss by directly blocking ions from leaking through nerve cell membranes,» said Ratnesh Lal, a professor of bioengineering at the University of California San Diego and co-senior author of the
study.
An FDA - approved
drug for high blood pressure, guanabenz, prevents myelin
loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new
study.
The
study raises the possibility that
drugs known as JAK inhibitors could be used to restore hair growth in multiple forms of hair
loss such as that induced by male pattern baldness, and additional types that occur when hair follicles are trapped in a resting state.
The anti-vascular endothelial growth factor
drugs ranibizumab and aflibercept, used to treat vision
loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost - effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a
study published online by JAMA Ophthalmology.
A first - in - human
study of a new polymer - free
drug - filled stent, which provides controlled
drug elution from an internal lumen, indicated non-inferior in - stent late lumen
loss at nine - months compared with historical zotarolimus - eluting stent (Resolute) data.
Bethesda, Md. (March 20, 2018)-- Minoxidil, a popular
drug used on the scalp to treat hair
loss, might improve blood flow to the brain, lower blood pressure and increase elasticity in the blood vessels if taken in an oral form, according to a new
study in mice.
In recent years, researchers have developed so - called «senolytic»
drugs that wipe out senescent cells in aging mice and mouse models of age - related disease, exploiting the high dependence of these cells on specific biochemical survival pathways.9, 10 In these
studies, senolytic
drugs have restored exercise capacity9 and formation of new blood and immune precursor cells11 in aging mice to near youthful norms, and prevented or treated mouse models of diseases of aging like osteoarthritis, 12 fibrotic lung disease, 13 hair
loss, 14 atherosclerosis, 15,16 and age - related diseases of the heart itself.9 UNITY Biotechnology is leading a growing charge toward the clinic, with human clinical trials expected to begin in 2019.
For some years an asthma
drug called amlexanox has been
studied for its ability to inhibit TBK1, and a previous experiment showed that when administered to obese mice, it caused weight
loss and increased the animals» sensitivity to insulin, helping improve their diabetes and fatty liver disease.
4/10/2007 National Weight -
Loss Study Open At Moores UCSD Cancer Center Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research study for weight loss employing an investigational combination drug therapy and behavioral modificat
Loss Study Open At Moores UCSD Cancer Center Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research study for weight loss employing an investigational combination drug therapy and behavioral modifica
Study Open At Moores UCSD Cancer Center Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research
study for weight loss employing an investigational combination drug therapy and behavioral modifica
study for weight
loss employing an investigational combination drug therapy and behavioral modificat
loss employing an investigational combination
drug therapy and behavioral modification.
April 30, 2015 Clinical trial for guanabenz as treatment for Multiple Sclerosis begins enrollment Patients are now being enrolled in a clinical trial conducted to
study guanabenz, an FDA - approved
drug to treat high blood pressure, as a potential therapeutic to reduce
loss of myelin in multiple sclerosis (MS) patients.
March 13, 2015 Blood pressure
drug protects against symptoms of multiple sclerosis in animal models An FDA - approved
drug for high blood pressure, guanabenz, prevents myelin
loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new
study.
Studies concluded that women with the highest phytate levels had the lowest levels of bone
loss in the spine and hips, similar to the outcomes of anti-osteoporosis
drugs, but without the
drugs» side effects.
Newcastle University researchers analyzed eight
studies that looked at how effective different weight -
loss methods (diet, exercise,
drugs) are for people with the FTO gene.
In a large two - year
study, among people who lost at least 5 % of their body weight in their first year on Belviq, 68 % of those who stayed on the
drug maintained their weight
loss in the second year, compared with only 50 % of people who stopped the
drug after a year.»
Berberine is now being
studied extensively and has been proven to lower blood sugar as well as the most commonly prescribed prescription
drug metformin (1, 2), aid in weight
loss, improve heart health, and several other benefits (3)
Additionally, it's important to note that the women in the above - mentioned
study were also put on a special diet and exercise plan - it was not the
drug alone that contributed to any weight
loss in those women with PCOS.
In this
study curcumin's ability to inhibit 5α - reductase was less than finasteride, a pharmaceutical
drug used topically to prevent further hair
loss and promote regrowth of hair.
Overweight people with a history of heart disease who take the prescription weight -
loss drug Meridia may be at increased risk of heart attack or stroke, according to a
study published this week in the New England Journal of Medicine.
In November 2011, FDA officials announced that PPA, a human - approved
drug found in weight
loss aids and nasal decongestants, eventually would be pulled from the market after a Yale
study revealed a link between the
drug's use and hemorrhage stroke in women.
A recent
study published in the Journal of the AVMA took a look at treatment of overweight dogs treated for this injury with surgery and non-surgical treatment in addition to weight
loss, physical therapy and non-steroidal anti-inflammatory
drugs.
Symptoms of Bladder Cancer: • Blood in the urine • Straining or pain during urination • Urinating often • Incontinence • Fatigue • Bone tenderness • Pain • Weight
loss FDA
Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer, FDA, June 15, 2011 The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case - control
study, British Medical Journal, May 31, 2012
In a new
study, researchers in Denmark assigned obese people to one of four liraglutide doses, a placebo or the weight -
loss drug orlistat.
Journals & Magazines ADHD Report Anxiety, Stress and Coping Autism Childhood Contemporary Hypnosis Dementia Depression and Anxiety
Drug and Alcohol Review Dyslexia Early Child Development and Care Eating Disorders Educational Assessment Journal of Gambling
Studies Journal of Happiness
Studies Journal of Mental Health and Aging Journal of Sex & Marital Therapy Journal of Sport and Exercise Psychology Journal of Substance Abuse Treatment Language and Cognitive Processes
Loss, Grief & Care Mental Retardation and Developmental Disabilities Metaphor and Symbol Neuropsychological Rehabilitation Parenting Personal Relationships Personality and Individual Differences Psychiatric Bulletin Psychology of Men & Masculinity Psychology Today Stress and Health Substance Abuse Trauma, Violence & Abuse
Felitti and colleagues1 first described ACEs and defined it as exposure to psychological, physical or sexual abuse, and household dysfunction including substance abuse (problem drinking / alcoholic and / or street
drugs), mental illness, a mother treated violently and criminal behaviour in the household.1 Along with the initial ACE
study, other
studies have characterised ACEs as neglect, parental separation,
loss of family members or friends, long - term financial adversity and witness to violence.2 3 From the original cohort of 9508 American adults, more than half of respondents (52 %) experienced at least one adverse childhood event.1 Since the original cohort, ACE exposures have been investigated globally revealing comparable prevalence to the original cohort.4 5 More recently in 2014, a survey of 4000 American children found that 60.8 % of children had at least one form of direct experience of violence, crime or abuse.6 The ACE
study precipitated interest in the health conditions of adults maltreated as children as it revealed links to chronic diseases such as obesity, autoimmune diseases, heart, lung and liver diseases, and cancer in adulthood.1 Since then, further evidence has revealed relationships between ACEs and physical and mental health outcomes, such as increased risk of substance abuse, suicide and premature mortality.4 7
Journals & Magazines ADHD Report Anxiety, Stress and Coping Autism Childhood Contemporary Hypnosis Dementia Depression and Anxiety Dreaming
Drug and Alcohol Review Dyslexia Early Child Development and Care Eating Disorders Educational Assessment Illness, Crisis &
Loss Industrial - Organizational Psychologist Journal of Gambling
Studies Journal of Happiness
Studies Journal of Mental Health and Aging Journal of Sex & Marital Therapy Journal of Sport and Exercise Psychology Journal of Substance Abuse Treatment Language and Cognitive Processes
Loss, Grief & Care Mental Retardation and Developmental Disabilities Metaphor and Symbol Neuropsychological Rehabilitation Parenting Personal Relationships Personality and Individual Differences Psychiatric Bulletin Psychology of Men & Masculinity Psychology Today ReVision: A Journal of Consciousness and Transformation Stress and Health
Studies in Gender and Sexuality Substance Abuse Suicide and Life - Threatening Behavior Trauma, Violence & Abuse